graph Evidence gap map comparisons
trastuzumab based treatment
docetaxel plus carboplatin with trastuzumab followed by trastuzumab
Comparator:  vs doxorubicin plus cyclophosphamide followed by docetaxel; 
Risk of bias:  low;   some concerns;   high;  NA;